亚洲 · 股市与财经 · Mint
Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October
Sun Pharmaceutical Industries will hold a Board meeting on October 12, 2026, to approve the issuance of non-convertible debentures worth up to ₹15,000 crore to fund a bridge loan…
在 Mint 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.livemint.com)
